TNF Pharma - TNFA Company Cash Volume

Official company branding of TNF Pharmaceuticals (TNFA)

The cash balance history demonstrates how geopolitical tensions and logistics disruptions are hindering the development of new drugs. The indicator's current value reaches 0.00, driven by strict control over grants and investments aimed at combating age-related pathologies. Unique patents on conjugates and powerful lobbying ensure the stability of TNF Pharmaceuticals (TNFA) positions, creating significant barriers to entry for new players in the sector.

TNFA - tnfpharma.com Company Cash Volume over the range 07/25/2024 - 09/25/2025

Metric breakdowns and analytics for TNF Pharmaceuticals (TNFA)

- stock value and consensus price forecast:
Comprehensive company analysis:TNF Pharmaceuticals
Signature product of TNF Pharma

Developing new drugs requires colossal expenditures from TNF Pharmaceuticals (TNFA), leading to a systematic depletion of reserves. The cash balance trend reflects the market consensus regarding the issuer's current volume of liquid assets. This indicator measures the company's ability to cover operating expenses without external borrowing. While accumulating funds minimizes default risk, excess cash reduces the overall return on equity. The current trend confirms the business's dependence on regular secondary share offerings.

Competitors of TNF Pharmaceuticals

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Company Cash on Hand Telomir Pharmaceuticals TELO|Company Cash Volume RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Company Total Cash Volume|RLYB - Company Cash Funds|LEXX (Lexaria Bioscience Corp.) - Company Cash and Cash Equivalents|pulmatrix.com (PULM) - Company Cash Funds|PTHL (Pheton) - Company Cash Funds|Company Cash Funds Aptorum|Company Cash Reserve Lyra Therapeutics Inc. LYRA|Company Cash Volume IBO|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance